Xeris Biopharma Holdings Inc (XERS)
Total Non-Current Liabilities
$232.07M
Quarterly · Period ending: · USD
XERS Total Non-Current Liabilities
Latest reported$260.26Mperiod ending
Latest reported$260.26Mperiod ending
XERS FY Total Non-Current Liabilities ($62.94M → $260.26M)
Annual total non-current liabilities
High-resolution chart · PNG
XERS total non-current liabilities history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 260,264,000 | |
| 252,232,000 | |
| 234,191,000 | |
| 225,714,000 | |
| 130,090,000 | |
| 97,183,000 | |
| 67,213,000 | |
| 34,450,000 | |
| 97,968,000 | |
| 62,940,000 |